Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Thursday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE opened at $0.00 on Thursday. The stock has a market cap of $681.00, a P/E ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $2.47. The company has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.01.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.